| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
This week's research roundup features a study on the prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma.
Top highlights include: Changes to outpatient visitor restrictions in Rochester, MN, Mayo Clinic Q&A podcast on the COVID-19 delta variant, and respiratory illnesses on the rise with symptoms similar to COVID-19.
This week’s research roundup features a study on acute treatments for episodic migraine in adults: A systematic review and meta-analysis.
Topic includes: new vaccine platform invented by Mayo enters COVID-19 clinical trial, Q&A on vaccination and precautions and the new work-life balancing act.
This week’s research roundup features a study on how ciliopathy protein HYLS1 coordinates the biogenesis and signaling of primary cilia by activating the ciliary lipid kinase PIPKIγ.
This week’s research roundup features a study on MAP3K7-IKK inflammatory signaling modulates AR protein degradation and prostate cancer progression.
This week’s research roundup features a study on acute treatments for episodic migraine in adults: A systematic review and meta-analysis.
Top stories include: COVID-19 travel tips for people with weakened immune systems, Mayo clinic Q&A on examining reports of heart inflammation in young people after second COVID-19 vaccine, and what Mayo Clinic has to offer with COVID-19 walk in vaccine clinics in Minnesota.
This week’s research roundup features a study on how senolytics reduced coronavirus-related mortality in old mice.
Top highlights include: Overcoming pandemic procrastination and how senolytics reduce COVID-19 symptoms in preclinical studies.
This week’s research roundup features a study on therapeutic trials in adult FSGS and lessons learned for the road forward.
COVID-19 weekly news: Mayo Clinic updates masking, in-person meeting guidance; brushing off the ‘social rust’ as COVID-19 restrictions ease and how patients are now permitted two visitors at Mayo Clinic Health system locations.
This week’s research roundup features a study on how RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.